Cissy Nsubuga

Cissy Nsubuga

Auto-generated profile, based on publicly available information

Cissy Nsubuga

One Brave Idea and Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women’s Hospital, Boston, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2022 in Science Translational Medicine
Verified
Journal Article
Closed access
WZWandi Zhu
Wandi Zhu
SGShihui Guo
Shihui Guo
MHMax Homilius
Max Homilius
CNCissy Nsubuga
Cissy Nsubuga
SWShane H. Wright
Shane H. Wright
CMCalum A. MacRae
Calum A. MacRae
Hematopoietic cell selection based on PIEZO1 expression drives thrombosis risk in type 2 diabetes.

4 December 2023 in Nature Genetics
Verified
Journal Article
Open access
PDF file
MHMax Homilius
Max Homilius
WZWandi Zhu
Wandi Zhu
SESamuel S. Eddy
Samuel S. Eddy
PTPatrick C. Thompson
Patrick C. Thompson
HZHuahua Zheng
Huahua Zheng
RDRahul C. Deo
Rahul C. Deo
Although genome-wide association studies (GWAS) have successfully linked genetic risk loci to various disorders, identifying underlying cellular biological mechanisms remains challenging due to the complex nature of common diseases. We established a framework using human peripheral blood cells, physical, chemical and pharmacological perturbations, and flow cytometry-based functional readouts to reveal latent cellular processes and performed GWAS based on these evoked traits in up to 2,600 individuals. We identified 119 genomic loci implicating 96 genes associated with these cellular responses and discovered associations between evoked blood phenotypes and subsets of common diseases. We found a population of pro-inflammatory anti-apoptotic neutrophils prevalent in individuals with specific subsets of cardiometabolic disease. Multigenic models based on this trait predicted the risk of developing chronic kidney disease in type 2 diabetes patients. By expanding the phenotypic space for human genetic studies, we could identify variants associated with large effect response differences, stratify patients and efficiently characterize the underlying biology.